SalvaRx Group (SALV) Share Price, News & Analysis

Company Overview

SalvaRx Group plc discovers and develops immune-oncology drugs. The company is based in Ramsey, Isle of Man.

Key Stats

• Today's Range: N/A
• 50-Day Range: 4.50 to 4.50
• 52-Week Range: N/A
• Volume: 50,758 shs
• Average Volume: 50,758 shs
• Market Capitalization: £1.65 million
• P/E Ratio: 0.03
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SALV Stock Analysis - Frequently Asked Questions

How do I buy shares of SalvaRx Group?

Shares of SALV stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of SalvaRx Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that SalvaRx Group investors own include Premier African Minerals (PREM), Cradle Arc (CRA), Cora Gold (CORA), Big Sofa Technologies Group (BST), Bahamas Petroleum (BPC), Bacanora Lithium (BCN) and AutoZone (AZO).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: LON:SALV
• Previous Symbol: LON:3LEG
• CIK: N/A
• Web: www.salvarx.io
• Phone: +44-1624-811611
• Fax: N/A
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 0.03
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 14.50
• Current Ratio: 1.89
• Quick Ratio: 1.89

Sales & Book Value

• Annual Sales: £64.50 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 3.50
• Book Value: GBX 15.40 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 36,700,000
• Free Float: N/A
• Market Cap: £1.65 million
• Optionable: Not Optionable
• Beta: N/A